{"id":"W4410706661","doi":"10.1093/ced/llaf215","title":"Outcomes of Psoriasis Area and Severity Index (PASI) and PASI components in two phase III trials of deucravacitinib in patients with moderate to severe plaque psoriasis","year":2025,"lang":"en","type":"article","venue":"Clinical and Experimental Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Queen's University","funders":"Manchester Biomedical Research Centre; Bristol-Myers Squibb Canada; Samsung; LEO Pharma; Sun Pharma; Celgene; Teva Pharmaceutical Industries; National Institute for Health and Care Research; XBiotech; Celltrion; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Placebo; Medicine; Psoriasis Area and Severity Index; Plaque psoriasis; Erythema; Psoriasis; Desquamation; Internal medicine; Severity of illness; Clinical trial; Surgery; Gastroenterology; Dermatology; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003018522,0.0008604943,0.001963877,0.0003004971,0.0004650205,0.0007646074,0.000401371,0.0008417873,0.001615876],"category_scores_gemma":[0.001474469,0.0002787625,0.001362029,0.0002886648,0.0004094104,0.0005643971,0.0002567833,0.002243158,0.0002545175],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006892282,"about_ca_system_score_gemma":0.0008612871,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004909465,"about_ca_topic_score_gemma":0.00147475,"domain_scores_codex":[0.9989944,0.000556825,0.00009252041,0.000124856,0.0001035056,0.0001278953],"domain_scores_gemma":[0.9991738,0.0002045242,0.0002644535,0.00005424011,0.00008685956,0.0002160901],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7544147,0.03637375,0.01168829,0.00137319,0.002786403,0.0001187824,0.0002354298,0.002211188,0.04930994,0.0003139456,0.002359404,0.138815],"study_design_scores_gemma":[0.5280918,0.4094259,0.04491204,0.00006529762,0.001199187,0.0003809365,0.00006891622,0.001694698,0.01029217,0.0002670977,0.003554771,0.00004720529],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892269,0.004694308,0.0006907111,0.0002953412,0.0001013495,0.00231619,0.0005544518,0.00005284703,0.002067948],"genre_scores_gemma":[0.9956132,0.0009244893,0.0007112493,0.0002101964,0.00005582609,0.001054839,0.0005844657,0.000007044548,0.0008387485],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003018522,"threshold_uncertainty_score":0.01596367,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04650189664611037,"score_gpt":0.351055705697812,"score_spread":0.3045538090517016,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}